BCL2 and hepatocellular carcinoma: Likewise, the anti-apoptotic effect of the miR-1343-3p inhibitor was evidenced by the downregulation of Bax and the upregulation of Bcl-2; however, this phenomenon was reversed by ASMTL-AS1 silencing in HCC cells (Figure 4(b)).